Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis.
暂无分享,去创建一个
J J Anderson | M. Dougados | D. Felson | D. M. van der Heijde | G. Baron | J. Anderson | D. Heijde | Jennifer J. Anderson | D T Felson | D van der Heijde | M Dougados | G Baron | G. Baron | J. Anderson | D. V. D. Heijde | D. Heijde
[1] D. Felson,et al. Preliminary definition of improvement in juvenile arthritis. , 1997, Arthritis and rheumatism.
[2] D. Felson,et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials : Part 3: Rheumatoid Arthritis: Response , 1998 .
[3] M. Dougados,et al. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. , 2001, Arthritis and rheumatism.
[4] M. Dougados,et al. Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study. , 1994, Scandinavian journal of rheumatology.
[5] M. Ward,et al. Validity and sensitivity to change of spondylitis-specific measures of functional disability. , 1999, The Journal of rheumatology.
[6] M. Dougados,et al. A double blind crossover placebo controlled trial of ximoprofen in as. , 1989, The Journal of rheumatology.
[7] J J Anderson,et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[8] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[9] M. Dougados,et al. Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. , 1999, Rheumatology.
[10] M. Dougados,et al. A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. , 1999, The Journal of rheumatology.
[11] M. Dougados,et al. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. , 1997, The Journal of rheumatology.
[12] M. Dougados,et al. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. , 1999, The Journal of rheumatology.
[13] M. Dougados,et al. Evaluation of a functional index and an articular index in ankylosing spondylitis. , 1988, The Journal of rheumatology.
[14] J M Bland,et al. Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .
[15] J P Nakache,et al. Evaluation of a functional index for patients with ankylosing spondylitis. , 1990, The Journal of rheumatology.
[16] M. Prevoo,et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. , 1996, Arthritis and rheumatism.
[17] H. Holman,et al. Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.